Home NDC 27241-246 Methazolamide
Product NDC 27241-246
11-digit product format 272410246
Labeler code 27241
Product ID 27241-246_924990c8-715d-4601-87af-e27fde11f70b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Methazolamide
Dosage form TABLET
Route ORAL
Labeler Ajanta Pharma USA Inc.
Application ANDA217408
Marketing category ANDA
Marketing start 2026-02-09
Substance METHAZOLAMIDE
Active strength 25 mg/1
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A217408-001 METHAZOLAMIDE METHAZOLAMIDE 25MG TABLET / ORAL AB 2026-02-09 A217408-002 METHAZOLAMIDE METHAZOLAMIDE 50MG TABLET / ORAL AB 2026-02-09
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A217408-001 METHAZOLAMIDE 25MG TABLET / ORAL AB 2026-02-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 A217408-002 METHAZOLAMIDE 50MG TABLET / ORAL AB 2026-02-09 c2088c7a36db…2026-09-14 22:38:34 2026-08 A217408-001 METHAZOLAMIDE 25MG TABLET / ORAL AB 2026-02-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 A217408-002 METHAZOLAMIDE 50MG TABLET / ORAL AB 2026-02-09 84e616aacf4f…2026-08-18 06:07:40 2026-07 A217408-001 METHAZOLAMIDE 25MG TABLET / ORAL AB 2026-02-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A217408-002 METHAZOLAMIDE 50MG TABLET / ORAL AB 2026-02-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A217408-001 METHAZOLAMIDE 25MG TABLET / ORAL AB 2026-02-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A217408-002 METHAZOLAMIDE 50MG TABLET / ORAL AB 2026-02-09 011fe1cb6892…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A217408-001 METHAZOLAMIDE 25MG TABLET / ORAL AB 2026-02-09 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A217408-002 METHAZOLAMIDE 50MG TABLET / ORAL AB 2026-02-09 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Methazolamide
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength METHAZOLAMIDE 25 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 27241-246-01 Methazolamide 100 in 1 BOTTLE TABLET 100 3
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 27241-246-01 27241024601 100 TABLET in 1 BOTTLE (27241-246-01) 100 tablet 2026-02-09 No No Current